Embolization Particle Market is expected to grow at a CAGR of 9.1% during the forecast period. Global Embolization Particle Market is expected to reach US$ 3.27 Bn. by 2029.To know about the Research Methodology :- Request Free Sample Report
Embolization Particle Market Definition
There raised occurrence of cancers and tumors is likely to drive the embolization particle marketplace over the forecast time period. The oncology segment is projected to grow at a CAGR of xx% during the forecast period owing to the upsurge in the incidence of most cancers globally has brought about robust expansion of the oncology segment. North America upholds the major share of the embolization particle market and is likely to reach USD 7xx.20 million by way of 2029.The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.Embolization Particle Market Dynamics
Embolization is a slightly invasive therapy to stop bleeding along with to prevent blood flow to a tumor so as to shrink it or in preparation for elimination. In this method, some embolized particles or materials are injected into the veins of the sufferers to block or reduce the blood flow to cancer cells. Embolization is an alternative for some patients with tumors that cannot be eliminated by means of surgical operation. There elevated incidence of cancers and tumors is probable to drive the embolization particle marketplace over the forecast time period. As per the National Cancer Institute 2018 Report, there have been round 1,735,350 new most cancer cases within the U.S. This variety is predicted to attain 23.6 million by 2030. Additionally, widespread technological improvements made in the healthcare enterprise are leading to diverse new product launches for the treatment of assorted chronic situations. Besides, the increasing attention among people about the embolization particle is in all likelihood to result in an increased demand for embolization debris over the anticipated time period. Furthermore, the growth inside the interventional process and upward thrust in the variety of minimally invasive surgical procedures due to advantageous and powerful effects are anticipated to assist the embolization particle marketplace within the years in advance. However, the lack of skilled interventional cardiologists might restrict the embolization particle market in the future.Embolization Particle Market Segment analysis
Based on the Application, the oncology segment is projected to grow at a CAGR of XX% during the forecast period. Though, the thriving in the superiority of cancer globally has led to a sturdy enlargement of the oncology section, that's predicted to record excessive growth for the duration of the forecast duration. The upsurge in the incidence of most cancers globally has brought about robust expansion of the oncology segment, which is expected to record high growth during the forecast period. According to Globocan, the incidence of liver cancer was 8.2% of the entire cancer occurrence in 2019, female breast cancer (11.6%), prostate most cancers (7.1%), and colorectal cancer (6.1%) Embolization debris is the primary products used in the remedy of malignancies. An increase in consciousness about uterine fibroid embolization strategies (UFE) and benign prostatic hyperplasia treatment via embolization is predicted to enhance the marketplace inside the following couple of years.Embolization Particle Market Regional analysis
North America is anticipated to lead the worldwide embolization particle market at some point of the forecast duration. America maintains the biggest share of the embolization particle market and is likely to reach USD 7xx.20 million by way of 2029. The Americas lead the worldwide embolization particle market as a result of the presence of the sturdy economic condition, massive development in the healthcare domain, and the focus of studies establishments on updating technology for new and advanced diagnosis and treatment techniques. Moreover, advanced hospitals infrastructures and availability of skilled healthcare professional is similarly including stimulus to the boom of the market. In 2019, there will be approximately 140,690 cancer cases diagnosed and about 103,250 cancer deaths among the oldest old in the US. Cancer accounts for 8% of all cases diagnosed in the US but 17% of all cancer deaths. Europe is a prominent area of the embolization particle marketplace because of a growth within the acceptance of slightly invasive processes for treatment. Embolization approaches have fewer facet-results because of their minimally invasive nature and faster wound healing process. The upward thrust in awareness amongst patients regarding embolization procedures and their related benefits inclusive of brief clinic stay and rapid healing procedure also contributes to market growth. The objective of the report is to present a comprehensive analysis of the Global Embolization Particle Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Embolization Particle Market dynamics, structure by analysing the market segments and projects the Global Embolization Particle Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Embolization Particle Market make the report investor’s guide.Scope of the Global Embolization Particle Market: Inquire before buying
Global Embolization Particle Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 1.63 Bn. Forecast Period 2022 to 2029 CAGR: 9.1% Market Size in 2029: US $ 3.27 Bn. Segments Covered: by Particles • Microspheres Particles • Drug-Eluting Beads (DEBs) • Radio-Embolic Microspheres by Application •Trauma Embolization • Peripheral Vascular Disease • Liver Tumor Embolization • oncology • Uterine Fibroid Embolization • Others Global Embolization Particle Market, By Regions
• North America • Europe • Asia-Pacific • South America • Middle East and Africa (MEA)Key Players operating the Global Embolization Particle Market
• Sirtex Medical • Merit Medical • Cook Medical • BTG Medical • Boston Scientific Corporation • Terumo Corporation • HENGRUI Medical • INterface BIOmaterials B.V. • Alicon • Guerbet • Medtronics • Abbott Laboratories • Edwards Lifesciences • Johnson & Johnson • Pfizer, Inc. • St. Jude Medical, Inc. Frequently Asked Questions: 1. Which region has the largest share in Global Embolization Particle Market? Ans: Asia Pacific region holds the highest share in 2021. 2. What is the growth rate of Global Embolization Particle Market? Ans: The Global Embolization Particle Market is growing at a CAGR of 9.1% during forecasting period 2022-2029. 3. What is scope of the Global Embolization Particle Market report? Ans: Global Embolization Particle Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. What is the study period of this market? Ans: The Global Embolization Particle Market is studied from 2021 to 2029.
Global Embolization Particle Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Embolization Particle Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 4.8. Patent Registration 5. Supply Side and Demand Side Indicators 6. Global Embolization Particle Market Analysis and Forecast 6.1. Global Embolization Particle Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Embolization Particle Market Analysis and Forecast, By Particle Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Embolization Particle Market Value Share Analysis, By Particle Type 7.4. Global Embolization Particle Market Size (US$ Mn) Forecast, By Particle Type 7.5. Global Embolization Particle Market Analysis, By Particle Type 7.6. Global Embolization Particle Market Attractiveness Analysis, By Particle Type 8. Global Embolization Particle Market Analysis and Forecast, By Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Embolization Particle Market Value Share Analysis, By Application 8.4. Global Embolization Particle Market Size (US$ Mn) Forecast, By Application 8.5. Global Embolization Particle Market Analysis, By Application 8.6. Global Embolization Particle Market Attractiveness Analysis, By Application 9. Global Embolization Particle Market Analysis, by Region 9.1. Global Embolization Particle Market Value Share Analysis, by Region 9.2. Global Embolization Particle Market Size (US$ Mn) Forecast, by Region 9.3. Global Embolization Particle Market Attractiveness Analysis, by Region 10. North America Embolization Particle Market Analysis 10.1. Key Findings 10.2. North America Embolization Particle Market Overview 10.3. North America Embolization Particle Market Value Share Analysis, By Particle Type 10.4. North America Embolization Particle Market Forecast, By Particle Type 10.4.1. Microspheres 10.4.2. Particles 10.4.3. Drug-Eluting Beads (DEBs) 10.4.4. Radio-Embolic Microspheres 10.5. North America Embolization Particle Market Value Share Analysis, By Application 10.6. North America Embolization Particle Market Forecast, By Application 10.6.1. Trauma Embolization 10.6.2. Peripheral Vascular Disease 10.6.3. Liver Tumor Embolization 10.6.4. oncology 10.6.5. Uterine Fibroid Embolization 10.6.6. Others 10.7. North America Embolization Particle Market Value Share Analysis, by Country 10.8. North America Embolization Particle Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Embolization Particle Market Analysis, by Country 10.10. U.S. Embolization Particle Market Forecast, By Particle Type 10.10.1. Microspheres 10.10.2. Particles 10.10.3. Drug-Eluting Beads (DEBs) 10.10.4. Radio-Embolic Microspheres 10.11. U.S. Embolization Particle Market Forecast, By Application 10.11.1. Trauma Embolization 10.11.2. Peripheral Vascular Disease 10.11.3. Liver Tumor Embolization 10.11.4. oncology 10.11.5. Uterine Fibroid Embolization 10.11.6. Others 10.12. Canada Embolization Particle Market Forecast, By Particle Type 10.12.1. Microspheres 10.12.2. Particles 10.12.3. Drug-Eluting Beads (DEBs) 10.12.4. Radio-Embolic Microspheres 10.13. Canada Embolization Particle Market Forecast, By Application 10.13.1. Trauma Embolization 10.13.2. Peripheral Vascular Disease 10.13.3. Liver Tumor Embolization 10.13.4. oncology 10.13.5. Uterine Fibroid Embolization 10.13.6. Others 10.14. North America Embolization Particle Market Attractiveness Analysis 10.14.1. By Particle Type 10.14.2. By Application 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Development 11. Europe Embolization Particle Market Analysis 11.1. Key Findings 11.2. Europe Embolization Particle Market Overview 11.3. Europe Embolization Particle Market Value Share Analysis, By Particle Type 11.4. Europe Embolization Particle Market Forecast, By Particle Type 11.4.1. Microspheres 11.4.2. Particles 11.4.3. Drug-Eluting Beads (DEBs) 11.4.4. Radio-Embolic Microspheres 11.5. Europe Embolization Particle Market Value Share Analysis, By Application 11.6. Europe Embolization Particle Market Forecast, By Application 11.6.1. Trauma Embolization 11.6.2. Peripheral Vascular Disease 11.6.3. Liver Tumor Embolization 11.6.4. oncology 11.6.5. Uterine Fibroid Embolization 11.6.6. Others 11.7. Europe Embolization Particle Market Value Share Analysis, by Country 11.8. Europe Embolization Particle Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Embolization Particle Market Analysis, by Country 11.10. Germany Embolization Particle Market Forecast, By Particle Type 11.10.1. Microspheres 11.10.2. Particles 11.10.3. Drug-Eluting Beads (DEBs) 11.10.4. Radio-Embolic Microspheres 11.11. Germany Embolization Particle Market Forecast, By Application 11.11.1. Trauma Embolization 11.11.2. Peripheral Vascular Disease 11.11.3. Liver Tumor Embolization 11.11.4. oncology 11.11.5. Uterine Fibroid Embolization 11.11.6. Others 11.12. U.K. Embolization Particle Market Forecast, By Particle Type 11.12.1. Microspheres 11.12.2. Particles 11.12.3. Drug-Eluting Beads (DEBs) 11.12.4. Radio-Embolic Microspheres 11.13. U.K. Embolization Particle Market Forecast, By Application 11.13.1. Trauma Embolization 11.13.2. Peripheral Vascular Disease 11.13.3. Liver Tumor Embolization 11.13.4. oncology 11.13.5. Uterine Fibroid Embolization 11.13.6. Others 11.14. France Embolization Particle Market Forecast, By Particle Type 11.14.1. Microspheres 11.14.2. Particles 11.14.3. Drug-Eluting Beads (DEBs) 11.14.4. Radio-Embolic Microspheres 11.15. France Embolization Particle Market Forecast, By Application 11.15.1. Trauma Embolization 11.15.2. Peripheral Vascular Disease 11.15.3. Liver Tumor Embolization 11.15.4. oncology 11.15.5. Uterine Fibroid Embolization 11.15.6. Others 11.16. Italy Embolization Particle Market Forecast, By Particle Type 11.16.1. Microspheres 11.16.2. Particles 11.16.3. Drug-Eluting Beads (DEBs) 11.16.4. Radio-Embolic Microspheres 11.17. Italy Embolization Particle Market Forecast, By Application 11.17.1. Trauma Embolization 11.17.2. Peripheral Vascular Disease 11.17.3. Liver Tumor Embolization 11.17.4. oncology 11.17.5. Uterine Fibroid Embolization 11.17.6. Others 11.18. Spain Embolization Particle Market Forecast, By Particle Type 11.18.1. Microspheres 11.18.2. Particles 11.18.3. Drug-Eluting Beads (DEBs) 11.18.4. Radio-Embolic Microspheres 11.19. Spain Embolization Particle Market Forecast, By Application 11.19.1. Trauma Embolization 11.19.2. Peripheral Vascular Disease 11.19.3. Liver Tumor Embolization 11.19.4. oncology 11.19.5. Uterine Fibroid Embolization 11.19.6. Others 11.20. Rest of Europe Embolization Particle Market Forecast, By Particle Type 11.20.1. Microspheres 11.20.2. Particles 11.20.3. Drug-Eluting Beads (DEBs) 11.20.4. Radio-Embolic Microspheres 11.21. Rest of Europe Embolization Particle Market Forecast, By Application 11.21.1. Trauma Embolization 11.21.2. Peripheral Vascular Disease 11.21.3. Liver Tumor Embolization 11.21.4. oncology 11.21.5. Uterine Fibroid Embolization 11.21.6. Others 11.22. Europe Embolization Particle Market Attractiveness Analysis 11.22.1. By Particle Type 11.22.2. By Application 11.23. PEST Analysis 11.24. Key Trend 11.25. Key Development 12. Asia Pacific Embolization Particle Market Analysis 12.1. Key Findings 12.2. Asia Pacific Embolization Particle Market Overview 12.3. Asia Pacific Embolization Particle Market Value Share Analysis, By Particle Type 12.4. Asia Pacific Embolization Particle Market Forecast, By Particle Type 12.4.1. Microspheres 12.4.2. Particles 12.4.3. Drug-Eluting Beads (DEBs) 12.4.4. Radio-Embolic Microspheres 12.5. Asia Pacific Embolization Particle Market Value Share Analysis, By Application 12.6. Asia Pacific Embolization Particle Market Forecast, By Application 12.6.1. Trauma Embolization 12.6.2. Peripheral Vascular Disease 12.6.3. Liver Tumor Embolization 12.6.4. oncology 12.6.5. Uterine Fibroid Embolization 12.6.6. Others 12.7. Asia Pacific Embolization Particle Market Value Share Analysis, by Country 12.8. Asia Pacific Embolization Particle Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Embolization Particle Market Analysis, by Country 12.10. China Embolization Particle Market Forecast, By Particle Type 12.10.1. Microspheres 12.10.2. Particles 12.10.3. Drug-Eluting Beads (DEBs) 12.10.4. Radio-Embolic Microspheres 12.11. China Embolization Particle Market Forecast, By Application 12.11.1. Trauma Embolization 12.11.2. Peripheral Vascular Disease 12.11.3. Liver Tumor Embolization 12.11.4. oncology 12.11.5. Uterine Fibroid Embolization 12.11.6. Others 12.12. India Embolization Particle Market Forecast, By Particle Type 12.12.1. Microspheres 12.12.2. Particles 12.12.3. Drug-Eluting Beads (DEBs) 12.12.4. Radio-Embolic Microspheres 12.13. India Embolization Particle Market Forecast, By Application 12.13.1. Trauma Embolization 12.13.2. Peripheral Vascular Disease 12.13.3. Liver Tumor Embolization 12.13.4. oncology 12.13.5. Uterine Fibroid Embolization 12.13.6. Others 12.14. Japan Embolization Particle Market Forecast, By Particle Type 12.14.1. Microspheres 12.14.2. Particles 12.14.3. Drug-Eluting Beads (DEBs) 12.14.4. Radio-Embolic Microspheres 12.15. Japan Embolization Particle Market Forecast, By Application 12.15.1. Trauma Embolization 12.15.2. Peripheral Vascular Disease 12.15.3. Liver Tumor Embolization 12.15.4. oncology 12.15.5. Uterine Fibroid Embolization 12.15.6. Others 12.16. ASEAN Embolization Particle Market Forecast, By Particle Type 12.16.1. Microspheres 12.16.2. Particles 12.16.3. Drug-Eluting Beads (DEBs) 12.16.4. Radio-Embolic Microspheres 12.17. ASEAN Embolization Particle Market Forecast, By Application 12.17.1. Trauma Embolization 12.17.2. Peripheral Vascular Disease 12.17.3. Liver Tumor Embolization 12.17.4. oncology 12.17.5. Uterine Fibroid Embolization 12.17.6. Others 12.18. Rest of Asia Pacific Embolization Particle Market By Particle Type 12.18.1. Microspheres 12.18.2. Particles 12.18.3. Drug-Eluting Beads (DEBs) 12.18.4. Radio-Embolic Microspheres 12.19. Rest of Asia Pacific Embolization Particle Market By Application 12.19.1. Trauma Embolization 12.19.2. Peripheral Vascular Disease 12.19.3. Liver Tumor Embolization 12.19.4. oncology 12.19.5. Uterine Fibroid Embolization 12.19.6. Others 12.20. Asia Pacific Embolization Particle Market Attractiveness Analysis 12.20.1. By Particle Type 12.20.2. By Application 12.21. PEST Analysis 12.22. Key Trend 12.23. Key Development 13. Middle East & Africa Embolization Particle Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Embolization Particle Market Overview 13.3. Middle East & Africa Embolization Particle Market Value Share Analysis, By Particle Type 13.4. Middle East & Africa Embolization Particle Market Forecast, By Particle Type 13.4.1. Microspheres 13.4.2. Particles 13.4.3. Drug-Eluting Beads (DEBs) 13.4.4. Radio-Embolic Microspheres 13.5. Middle East & Africa Embolization Particle Market Value Share Analysis, By Application 13.6. Middle East & Africa Embolization Particle Market Forecast, By Application 13.6.1. Trauma Embolization 13.6.2. Peripheral Vascular Disease 13.6.3. Liver Tumor Embolization 13.6.4. oncology 13.6.5. Uterine Fibroid Embolization 13.6.6. Others 13.7. Middle East & Africa Embolization Particle Market Value Share Analysis, by Country 13.8. Middle East & Africa Embolization Particle Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Embolization Particle Market Analysis, by Country 13.10. GCC Embolization Particle Market Forecast, By Particle Type 13.10.1. Microspheres 13.10.2. Particles 13.10.3. Drug-Eluting Beads (DEBs) 13.10.4. Radio-Embolic Microspheres 13.11. GCC Embolization Particle Market Forecast, By Application 13.11.1. Trauma Embolization 13.11.2. Peripheral Vascular Disease 13.11.3. Liver Tumor Embolization 13.11.4. oncology 13.11.5. Uterine Fibroid Embolization 13.11.6. Others 13.12. South Africa Embolization Particle Market Forecast, By Particle Type 13.12.1. Microspheres 13.12.2. Particles 13.12.3. Drug-Eluting Beads (DEBs) 13.12.4. Radio-Embolic Microspheres 13.13. South Africa Embolization Particle Market Forecast, By Application 13.13.1. Trauma Embolization 13.13.2. Peripheral Vascular Disease 13.13.3. Liver Tumor Embolization 13.13.4. oncology 13.13.5. Uterine Fibroid Embolization 13.13.6. Others 13.14. Rest of Middle East & Africa Embolization Particle Market Forecast, By Particle Type 13.14.1. Microspheres 13.14.2. Particles 13.14.3. Drug-Eluting Beads (DEBs) 13.14.4. Radio-Embolic Microspheres 13.15. Rest of Middle East & Africa Embolization Particle Market Forecast, By Application 13.15.1. Trauma Embolization 13.15.2. Peripheral Vascular Disease 13.15.3. Liver Tumor Embolization 13.15.4. oncology 13.15.5. Uterine Fibroid Embolization 13.15.6. Others 13.16. Middle East & Africa Embolization Particle Market Attractiveness Analysis 13.16.1. By Particle Type 13.16.2. By Application 13.17. PEST Analysis 13.18. Key Trend 13.19. Key Development 14. South America Embolization Particle Market Analysis 14.1. Key Findings 14.2. South America Embolization Particle Market Overview 14.3. South America Embolization Particle Market Value Share Analysis, By Particle Type 14.4. South America Embolization Particle Market Forecast, By Particle Type 14.4.1. Microspheres 14.4.2. Particles 14.4.3. Drug-Eluting Beads (DEBs) 14.4.4. Radio-Embolic Microspheres 14.5. South America Embolization Particle Market Value Share Analysis, By Application 14.6. South America Embolization Particle Market Forecast, By Application 14.6.1. Trauma Embolization 14.6.2. Peripheral Vascular Disease 14.6.3. Liver Tumor Embolization 14.6.4. oncology 14.6.5. Uterine Fibroid Embolization 14.6.6. Others 14.7. South America Embolization Particle Market Value Share Analysis, by Country 14.8. South America Embolization Particle Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. Brazil Embolization Particle Market Forecast, By Particle Type 14.9.1. Microspheres 14.9.2. Particles 14.9.3. Drug-Eluting Beads (DEBs) 14.9.4. Radio-Embolic Microspheres 14.10. Brazil Embolization Particle Market Forecast, By Application 14.10.1. Trauma Embolization 14.10.2. Peripheral Vascular Disease 14.10.3. Liver Tumor Embolization 14.10.4. oncology 14.10.5. Uterine Fibroid Embolization 14.10.6. Others 14.11. Mexico Embolization Particle Market Forecast, By Particle Type 14.11.1. Microspheres 14.11.2. Particles 14.11.3. Drug-Eluting Beads (DEBs) 14.11.4. Radio-Embolic Microspheres 14.12. Mexico Embolization Particle Market Forecast, By Application 14.12.1. Trauma Embolization 14.12.2. Peripheral Vascular Disease 14.12.3. Liver Tumor Embolization 14.12.4. oncology 14.12.5. Uterine Fibroid Embolization 14.12.6. Others 14.13. Rest of South America Embolization Particle Market Forecast, By Particle Type 14.13.1. Microspheres 14.13.2. Particles 14.13.3. Drug-Eluting Beads (DEBs) 14.13.4. Radio-Embolic Microspheres 14.14. Rest of South America Embolization Particle Market Forecast, By Application 14.14.1. Trauma Embolization 14.14.2. Peripheral Vascular Disease 14.14.3. Liver Tumor Embolization 14.14.4. oncology 14.14.5. Uterine Fibroid Embolization 14.14.6. Others 14.15. South America Embolization Particle Market Attractiveness Analysis 14.15.1. By Particle Type 14.15.2. By Application 14.16. PEST Analysis 14.17. Key Trend 14.18. Key Development 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.4. M&A by Regions, Investment and Applications 15.2.5. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Sirtex Medical 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Company Footprint 15.3.2. Merit Medical 15.3.3. Cook Medical 15.3.4. BTG Medical 15.3.5. Boston Scientific Corporation 15.3.6. Terumo Corporation 15.3.7. HENGRUI Medical 15.3.8. INterface BIOmaterials B.V. 15.3.9. Alicon 15.3.10. Guerbet 15.3.11. Medtronics 15.3.12. Abbott Laboratories 15.3.13. Edwards Lifesciences 15.3.14. Johnson & Johnson 15.3.15. Pfizer, Inc. 15.3.16. St. Jude Medical, Inc. 16. Primary Key Insights